Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/BF00375730 | DOI Listing |
Publication Analysis
Top Keywords
persistent etretinate
4
etretinate levels
4
levels plasma
4
plasma changing
4
changing therapy
4
therapy acitretin
4
persistent
1
levels
1
plasma
1
changing
1
Similar Publications
Antibiotic, hormonal/metabolic, and retinoid therapies for hidradenitis suppurativa.
J Am Acad Dermatol
December 2024
Department of Dermatology, Stanford University School of Medicine, Redwood City, California. Electronic address:
Article Synopsis
- Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition with unclear causes, making treatment challenging.
- This study reviews the effectiveness and safety of antibiotics, hormonal treatments, and oral retinoids in managing HS.
- Results showed that while antibiotics were effective, hormonal therapies and oral retinoids also showed potential for symptom relief, highlighting the need for customized treatment plans for patients.
Adult-onset erythrokeratodermia variabilis (EKV) triggered by pregnancy and crash dieting: A rare case report.
J Pak Med Assoc
September 2024
Department of Dermatology, PNS Shifa Hospital, Karachi, Pakistan.
Article Synopsis
- Erythrokeratodermia variabilis (EKV) is a rare genetic skin condition that involves changing red patches and fixed thick areas of skin, typically starting in infancy.
- A case is presented where a patient experienced EKV symptoms for the first time as an adult, which worsened during pregnancy but improved spontaneously after childbirth.
- After trying a crash diet, the patient developed more persistent symptoms that didn't resolve on their own, but showed significant improvement with treatment using systemic retinoids.
A retrospective analysis of 65 patients with acrodermatitis continua of Hallopeau.
Exp Dermatol
March 2024
Division of Dermatology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Article Synopsis
- Limited data exists on acrodermatitis continua of Hallopeau (ACH) among Asian populations, with a study of 65 patients revealing that females are more frequently affected, and many developing generalized pustular psoriasis (GPP) after ACH onset.
- The average age of onset for ACH with GPP is significantly younger (around 28 years) compared to isolated ACH (around 40 years), indicating a possible trend among Asian patients.
- Treatment results show that acitretin and ciclosporin are the most commonly used non-biologic therapies, with interleukin-17 inhibitors appearing to be more effective than tumor necrosis factor inhibitors for managing ACH outcomes.
Methotrexate Versus Acitretin for Grover's Disease Refractory to Topical Therapies.
J Cutan Med Surg
March 2024
Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!